Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 3292810, 2 pages

Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine

1Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari “Aldo Moro”, Bari, Italy
2Institut de Biologie-Biology of Adaptation and Aging (B2A), Université Pierre et Marie Curie Paris 6, Paris, France
3Department of Clinical Neurosciences-Division of Stem Cell Neurobiology, Wellcome Trust-Medical Research Council Stem Cell Institute and NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK
4Biomedical Section, Tecnologica Research Institute, Crotone, Italy

Correspondence should be addressed to Andrea Ballini; ti.abinu@inillab.aerdna

Received 4 April 2017; Accepted 6 April 2017; Published 22 June 2017

Copyright © 2017 Andrea Ballini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Friedenstein, R. K. Chailakhyan, N. V. Latsinik, A. F. Panasyuk, and I. V. Keiliss-Borok, “Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo,” Transplantation, vol. 17, pp. 331–340, 1974. View at Publisher · View at Google Scholar
  2. B. Parekkadan and J. M. Milwid, “Mesenchymal stem cells as therapeutics,” Annual Review of Biomedical Engineering, vol. 12, pp. 87–117, 2010. View at Publisher · View at Google Scholar
  3. C. Lechanteur, A. Briquet, O. Giet, O. Delloye, E. Baudoux, and Y. Beguin, “Clinical-scale expansion of mesenchymal stromal cells: a large banking experience,” Journal of Translational Medicine, vol. 14, no. 1, p. 145, 2016. View at Google Scholar
  4. J. Galipeau, M. Krampera, J. Barrett et al., “International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials,” Cytotherapy, vol. 18, no. 2, pp. 151–159, 2016. View at Publisher · View at Google Scholar
  5. R. Fazzina, P. Iudicone, D. Fioravanti et al., “Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues,” Stem Cell Research & Therapy, vol. 7, no. 1, p. 122, 2016. View at Google Scholar
  6. T. Squillaro, G. Peluso, and U. Galderisi, “Clinical trials with mesenchymal stem cells: an update,” Cell Transplantation, vol. 25, no. 5, pp. 829–848, 2016. View at Publisher · View at Google Scholar
  7. M. Marrelli, F. Paduano, and M. Tatullo, “Human periapical cyst-mesenchymal stem cells differentiate into neuronal cells,” Journal of Dental Research, vol. 94, no. 6, pp. 843–852, 2015. View at Publisher · View at Google Scholar
  8. F. Paduano, M. Marrelli, L. J. White, K. M. Shakesheff, and M. Tatullo, “Odontogenic differentiation of human dental pulp stem cells on hydrogel scaffolds derived from decellularized bone extracellular matrix and collagen type I,” PloS One, vol. 11, no. 2, article e0148225, 2016. View at Publisher · View at Google Scholar
  9. A. Di Benedetto, G. Brunetti, F. Posa et al., “Osteogenic differentiation of mesenchymal stem cells from dental bud: role of integrins and cadherins,” Stem Cell Research, vol. 15, no. 3, pp. 618–628, 2015. View at Publisher · View at Google Scholar
  10. A. Uccelli and D. J. Prockop, “Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?” Current Opinion in Immunology, vol. 22, pp. 768–774, 2010. View at Publisher · View at Google Scholar
  11. D. J. Prockop and J. Y. Oh, “Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation,” Molecular Therapy, vol. 20, no. 1, pp. 14–20, 2012. View at Publisher · View at Google Scholar
  12. Y. Shi, G. Hu, J. Su et al., “Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair,” Cell Research, vol. 20, no. 5, pp. 510–518, 2010. View at Publisher · View at Google Scholar
  13. S. V. Boregowda and D. G. Phinney, “Quantifiable metrics for predicting MSC therapeutic efficacy,” Journal of Stem Cell Research & Therapy, vol. 6, no. 11, 2016. View at Publisher · View at Google Scholar